Resources for professionals

This section contains resources of interest to professionals.

596 - 600 of 635 documents
18 Nov 2015
The Lancet Oncology
Background The prostate-specific antigen (PSA) test is used to screen for prostate cancer but has a high false-positive rate that translates into...
18 Nov 2015
PLOS ONE
Inhibitors of Wnt signaling have been shown to be involved in prostate cancer (PC) metastasis; however the role of Sclerostin (Sost) has not yet been...
12 Nov 2015
Blood Journal
We report the results of a multi-center Phase I dose escalation study of the selective BTK inhibitor ONO/GS-4059 in 90 patients with relapsed/...
12 Nov 2015
BMC Cancer
Background Prior studies have described a reduced risk of developing ovarian cancer with the use of oral contraceptives. In this context, we...
11 Nov 2015
The Lancet Oncology
The prostate-specific antigen (PSA) test is used to screen for prostate cancer but has a high false-positive rate that translates into unnecessary...

Pages